Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933299

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933299

Coronary Stent Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Growth Factors of coronary stents Market

The global coronary stents market was valued at USD 7.02 billion in 2025 and is projected to grow from USD 7.38 billion in 2026 to USD 12.26 billion by 2034, registering a CAGR of 6.54% during 2026-2034. North America dominated the market in 2025 with a 33.55% share, supported by robust healthcare infrastructure, high prevalence of coronary artery diseases (CAD), and frequent product launches backed by regulatory approvals.

Coronary stents are small, tube-shaped devices inserted into coronary arteries to keep them open, primarily used in Percutaneous Coronary Interventions (PCI) to treat conditions like atherosclerosis. The rising global incidence of cardiovascular diseases, technological advancements in stenting procedures, and improved accuracy in PCI operations are driving adoption in both developed and emerging markets.

MARKET DRIVERS

Rising Prevalence of Coronary Heart Disease

The growing prevalence of coronary heart disorders globally is a key market driver. Sedentary lifestyles, stress, and unhealthy eating habits are contributing factors. According to the U.S. CDC, about 5% of adults aged 20+ had CAD in 2023, highlighting a significant patient pool driving demand for stents. Additionally, the aging global population, more prone to CAD, further propels market growth.

Technological Advancements

Innovations in stent design, such as drug-eluting stents (DES) and bioresorbable stents, have enhanced safety and clinical outcomes. Devices like Medtronic's Onyx Frontier DES (FDA approved in 2022) feature improved delivery systems, facilitating complex PCI procedures. Minimally invasive interventions, reduced restenosis rates, and enhanced stent flexibility are increasing adoption among cardiologists worldwide.

MARKET RESTRAINTS

Side Effects and Regulatory Barriers

Complications like arterial damage, allergic reactions, or restenosis can hinder adoption. Strict regulatory approvals also limit product entry in certain regions. Product recalls, such as Atrium Medical's iCast-covered stents in 2022, negatively impact patient trust and market expansion.

MARKET OPPORTUNITIES

Emerging regions present significant growth potential due to rising awareness of cardiovascular diseases, expansion of specialty hospitals, and establishment of catheterization labs. Initiatives like India's public heart health campaigns (2023) and hospital expansions in Australia and India in 2024 demonstrate increasing accessibility and awareness, creating opportunities for stent adoption.

MARKET TRENDS

Continuous innovations in coronary stents, including reducing strut thickness, improving flexibility, and introducing biodegradable polymers, are shaping market growth. Examples include Medinol's EluNIR-PERL DES, FDA approved in 2023, enhancing patient outcomes and procedural efficiency.

SEGMENTATION ANALYSIS

By Stent Type

  • Drug-eluting stents (DES) dominate with 76.51% market share in 2026, driven by regulatory approvals, clinical demand, and reduced restenosis rates. Abbott's XIENCE Sierra DES launched in India in 2024 exemplifies this trend.
  • Bare metal stents maintain moderate growth due to suitability in high-bleeding-risk patients.
  • Bioresorbable stents are expanding due to increasing elderly populations and chronic cardiovascular conditions.
  • Covered stents grow via product launches like BIOTRONIK's PK Papyrus in 2019 for emergency perforation treatments.

By Material

  • Metal-based stents (stainless steel, cobalt-chromium, platinum-chromium) dominate in 2024 and are projected to continue leading due to efficiency and durability.
  • Polymer-based stents (used in bioresorbable devices) are also witnessing growth due to clinical benefits.

By Deployment

  • Self-expandable stents accounted for 69.11% share in 2026, offering high clinical efficiency.
  • Balloon-expandable stents maintain stable growth, benefiting from technological enhancements and PCI procedures.

By Application

  • Chronic Coronary Syndrome (CCS) dominated in 2026 with 89.21% share, reflecting high CAD prevalence.
  • Acute Coronary Syndrome (ACS) segment grows due to rising PCI procedures for acute events.

By End-User

  • Hospitals & Ambulatory Surgical Centers (ASCs) dominate due to high procedure volumes, advanced infrastructure, and opening of new cardiac care facilities (e.g., Virginia, U.S., 2024).
  • Specialty clinics show moderate growth, fueled by increasing cardiologist networks and patient awareness.
  • Others (catheterization labs) are steadily expanding.

REGIONAL OUTLOOK

  • North America: USD 2.35 billion in 2025, dominating due to advanced infrastructure and high CAD prevalence.
  • Europe: Moderate growth; UK USD 0.51 billion and Germany USD 0.64 billion in 2026.
  • Asia Pacific: Rapid growth; Japan USD 0.25 billion, China USD 0.39 billion, India USD 0.33 billion in 2026, driven by hospital expansions and new stent launches (Terumo Ultimaster Nagomi in India, 2023).
  • Latin America & Middle East & Africa: Steady growth due to rising CAD cases and angioplasty procedures.

COMPETITIVE LANDSCAPE

Key players include Abbott, Medtronic, Boston Scientific, BIOTRONIK, Terumo, MicroPort, B. Braun SE, Stentys, Meril Life Sciences, and Relisys Medical. Strategic acquisitions, regulatory approvals, and clinical trials are the primary growth strategies. Notable developments: Abbott acquiring CSI in 2023 and MicroPort receiving NMPA approval for Firesorb in 2024.

CONCLUSION

The global coronary stents market is projected to grow steadily from USD 7.02 billion in 2025 to USD 12.26 billion by 2034, driven by rising CAD prevalence, technological advancements in stent design, and expansion of healthcare infrastructure worldwide. While procedural risks, regulatory barriers, and product recalls pose challenges, innovations such as drug-eluting, bioresorbable, and self-expandable stents, coupled with emerging regional opportunities, ensure a robust growth trajectory. North America maintains dominance, while Asia Pacific exhibits the highest growth potential, creating significant opportunities for both established and emerging market players.

Segmentation Stent Type, Material Type, Deployment, Application, End-user, and Region

By Stent Type * Drug Eluting Stent

  • Covered Stent
  • Bare Metal Stent
  • Bioresorbable Stent
  • Others (Dual Therapy Stents)

By Material Type * Metal

  • Polymer

By Deployment * Self-expandable

  • Balloon-expandable

By Application * Acute Coronary Syndrome (ACS)

  • Chronic Coronary Syndrome (CCS)

By End-user * Hospitals & ASCs

  • Specialty Clinics
  • Others

By Region * North America (By Stent Type, Material Type, Deployment, Application, End-user, and Country)

    • U.S.
    • Canada
  • Europe (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Product Code: FBI100065

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Coronary Artery Disease (CAD), by Key countries/sub-region, 2023/2025
  • 4.2. Technological Advancements in Coronary Stents
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Stent Type
    • 5.1.1. Drug Eluting Stent
    • 5.1.2. Covered Stent
    • 5.1.3. Bare Metal Stent
    • 5.1.4. Bioresorbable Stent
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Material Type
    • 5.2.1. Metal
    • 5.2.2. Polymer
  • 5.3. Market Analysis, Insights and Forecast - By Deployment
    • 5.3.1. Self-expandable
    • 5.3.2. Balloon-expandable
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Acute Coronary Syndrome (ACS)
    • 5.4.2. Chronic Coronary Syndrome (CCS)
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & ASCs
    • 5.5.2. Specialty Clinics
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Stent Type
    • 6.1.1. Drug Eluting Stent
    • 6.1.2. Covered Stent
    • 6.1.3. Bare Metal Stent
    • 6.1.4. Bioresorbable Stent
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Material Type
    • 6.2.1. Metal
    • 6.2.2. Polymer
  • 6.3. Market Analysis, Insights and Forecast - By Deployment
    • 6.3.1. Self-expandable
    • 6.3.2. Balloon-expandable
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Acute Coronary Syndrome (ACS)
    • 6.4.2. Chronic Coronary Syndrome (CCS)
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & ASCs
    • 6.5.2. Specialty Clinics
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Stent Type
    • 7.1.1. Drug Eluting Stent
    • 7.1.2. Covered Stent
    • 7.1.3. Bare Metal Stent
    • 7.1.4. Bioresorbable Stent
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Material Type
    • 7.2.1. Metal
    • 7.2.2. Polymer
  • 7.3. Market Analysis, Insights and Forecast - By Deployment
    • 7.3.1. Self-expandable
    • 7.3.2. Balloon-expandable
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Acute Coronary Syndrome (ACS)
    • 7.4.2. Chronic Coronary Syndrome (CCS)
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & ASCs
    • 7.5.2. Specialty Clinics
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Stent Type
    • 8.1.1. Drug Eluting Stent
    • 8.1.2. Covered Stent
    • 8.1.3. Bare Metal Stent
    • 8.1.4. Bioresorbable Stent
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Material Type
    • 8.2.1. Metal
    • 8.2.2. Polymer
  • 8.3. Market Analysis, Insights and Forecast - By Deployment
    • 8.3.1. Self-expandable
    • 8.3.2. Balloon-expandable
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Acute Coronary Syndrome (ACS)
    • 8.4.2. Chronic Coronary Syndrome (CCS)
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & ASCs
    • 8.5.2. Specialty Clinics
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Stent Type
    • 9.1.1. Drug Eluting Stent
    • 9.1.2. Covered Stent
    • 9.1.3. Bare Metal Stent
    • 9.1.4. Bioresorbable Stent
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Material Type
    • 9.2.1. Metal
    • 9.2.2. Polymer
  • 9.3. Market Analysis, Insights and Forecast - By Deployment
    • 9.3.1. Self-expandable
    • 9.3.2. Balloon-expandable
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Acute Coronary Syndrome (ACS)
    • 9.4.2. Chronic Coronary Syndrome (CCS)
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & ASCs
    • 9.5.2. Specialty Clinics
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Stent Type
    • 10.1.1. Drug Eluting Stent
    • 10.1.2. Covered Stent
    • 10.1.3. Bare Metal Stent
    • 10.1.4. Bioresorbable Stent
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Material Type
    • 10.2.1. Metal
    • 10.2.2. Polymer
  • 10.3. Market Analysis, Insights and Forecast - By Deployment
    • 10.3.1. Self-expandable
    • 10.3.2. Balloon-expandable
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Acute Coronary Syndrome (ACS)
    • 10.4.2. Chronic Coronary Syndrome (CCS)
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & ASCs
    • 10.5.2. Specialty Clinics
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, Financials (based on availability), Recent Developments, Strategies, SWOT, Etc.)
    • 11.2.1. Medtronic
    • 11.2.2. Boston Scientific Corporation
    • 11.2.3. BIOTRONIK SE & Co. KG
    • 11.2.4. Terumo Corporation
    • 11.2.5. Abbott
    • 11.2.6. Relisys Medical Devices Limited.
    • 11.2.7. B. Braun SE
    • 11.2.8. MicroPort Scientific Corporation
    • 11.2.9. Stentys S.A.
    • 11.2.10. Meril Life Sciences Pvt. Ltd.
Product Code: FBI100065

List of Tables

  • Table 1: Global Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 2: Global Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 3: Global Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 4: Global Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Coronary Stents Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 8: North America Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 9: North America Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 10: North America Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Coronary Stents Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 14: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 15: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 16: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 20: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 21: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 22: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 26: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 27: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 28: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 32: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 33: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 34: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Coronary Stents Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Coronary Stents Market Value Share (%), by Stent Type, 2025 & 2034
  • Figure 3: Global Coronary Stents Market Value Share (%), by Material Type, 2025 & 2034
  • Figure 4: Global Coronary Stents Market Value Share (%), by Deployment, 2025 & 2034
  • Figure 5: Global Coronary Stents Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global Coronary Stents Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global Coronary Stents Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 9: North America Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 10: North America Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 11: North America Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 12: North America Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 13: North America Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 14: North America Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 15: North America Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 16: North America Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 17: North America Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 18: North America Coronary Stents Market Value (USD billion), by Country, 2025 & 2034
  • Figure 19: North America Coronary Stents Market Value Share (%), by Country, 2025
  • Figure 20: Europe Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 21: Europe Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 22: Europe Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 23: Europe Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 24: Europe Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 25: Europe Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 26: Europe Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27: Europe Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 28: Europe Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29: Europe Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 30: Europe Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 31: Europe Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 32: Asia Pacific Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 33: Asia Pacific Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 34: Asia Pacific Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 35: Asia Pacific Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 36: Asia Pacific Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 37: Asia Pacific Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 38: Asia Pacific Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39: Asia Pacific Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 40: Asia Pacific Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 44: Latin America Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 45: Latin America Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 46: Latin America Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 47: Latin America Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 48: Latin America Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 49: Latin America Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 50: Latin America Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 51: Latin America Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 52: Latin America Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 53: Latin America Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 56: Middle East & Africa Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 57: Middle East & Africa Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 58: Middle East & Africa Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 59: Middle East & Africa Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 60: Middle East & Africa Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 61: Middle East & Africa Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 62: Middle East & Africa Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 65: Middle East & Africa Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East & Africa Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 68: Global Coronary Stents Market Share (%), By Company, 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!